Stability Indicating RP-HPLC Method for Determination of Valsartan in Pure and Pharmaceutical Formulation

被引:12
作者
Patro, S. K. [1 ]
Kanungo, S. K. [1 ]
Patro, V. J. [2 ]
Choudhury, N. S. K. [3 ]
机构
[1] Inst Pharm & Technol, Dept Pharmaceut Anal & Qual Assurance, Cuttack 754202, Orissa, India
[2] Coll Pharmaceut Sci, Ganjam, Orissa, India
[3] SCB Med Coll, Dept Pharm, Cuttack, Orissa, India
关键词
Valsartan; RP-HPLC; Degradation studies; ANTAGONIST; PROFILE; LC;
D O I
10.1155/2010/487197
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A simple, rapid and accurate and stability indicating RP-HPLC method was developed for the determination of valsartan in pure and tablet forms. The method showed a linear response for concentrations in the range of 50-175 mu g/mL using 0.01 M NH(4)H(2)PO(4) (pH 3.5) buffer: methanol [50: 50] as the mobile phase with detection at 210 nm and a flow rate of 1 mL/min and retention time 11.041 min. The method was statistically validated for accuracy, precision, linearity, ruggedness, robustness, forced degradation, solution stability and selectivity. Quantitative and recovery studies of the dosage form were also carried out and analyzed; the % RSD from recovery studies was found to be less than 1. Due to simplicity, rapidity and accuracy of the method, we believe that the method will be useful for routine quality control analysis.
引用
收藏
页码:246 / 252
页数:7
相关论文
共 9 条
[1]  
Budavari S., 1996, MERCK INDEX ENCY CHE, P1691
[2]  
CARSTENSEN JT, 2008, DRUG STABILITY, P358
[3]   PHARMACOLOGICAL PROFILE OF VALSARTAN - A POTENT, ORALLY-ACTIVE, NONPEPTIDE ANTAGONIST OF THE ANGIOTENSIN-II AT1-RECEPTOR SUBTYPE [J].
CRISCIONE, L ;
DEGASPARO, M ;
BUHLMAYER, P ;
WHITEBREAD, S ;
RAMJOUE, HPR ;
WOOD, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (02) :761-771
[4]   Valsartan: Preclinical and clinical profile of an antihypertensive angiotensin-II antagonist [J].
Criscione, L ;
Bradley, WA ;
Buhlmayer, P ;
Whitebread, S ;
Glazer, R ;
Lloyd, P ;
Mueller, P ;
deGasparo, M .
CARDIOVASCULAR DRUG REVIEWS, 1995, 13 (03) :230-250
[5]  
Rockville M., 2002, ABOUT US, P2150
[6]   Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first-derivative ultraviolet spectrophotometry and LC [J].
Satana, E ;
Altinay, S ;
Göger, NG ;
Özkan, SA ;
Sentürk, Z .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 25 (5-6) :1009-1013
[7]  
Snyder LR., 1997, Practical HPLC Method Development, P709
[8]   Comparison of UV- and second derivative-spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation [J].
Tatar, S ;
Saglik, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (02) :371-375
[9]  
Thurmann P A, 2000, Expert Opin Pharmacother, V1, P337, DOI 10.1517/14656566.1.2.337